Is the GlaxoSmithKline dividend sustainable?
GlaxoSmithKline at 1370p. This company is undergoing considerable change in its strategic objectives. It looks attractive on both market consensus dividend estimates and on trading range grounds. Returning to the subject of Glaxo SmithKline (GSK), I see that the share price is at 1370p. I point out that is very close to the basement level of a year…